Antibiotics Market Demand and Competitive Analysis by Leading Manufacturers 2022-2030

The Global Antibiotics Market size is estimated to be USD 47.12 billion in 2019 and is predicted to reach USD 70.27 billion by 2030 with a CAGR of 3.7% from 2020-2030.

Antibiotics are chemical compounds that kill or slows down the growth of disease causing microorganisms such as bacteria, fungi, and parasite. Since the introduction of medicine, antibiotics have become an essential component in modern healthcare industry. The role of antibiotics has expanded from treating serious medical conditions to preventing infections in surgical patients, protecting cancer patients and people with compromised immune systems.

Antibiotic resistance is directly related to the frequency of use of antibiotics. WHO estimated 4, 90, 000 people developed multi-drug resistant TB globally, and drug resistance is starting to complicate the fight against HIV and malaria in 2016. Moreover, without new antibiotics, it will be increasingly difficult to effectively treat infections, and procedures such as organ transplantation, chemotherapy, or common surgical procedures, which carry high risk of untreatable infections. Therefore, it important to ensure availability of both new and old antibiotics of special medical value.

Access Full Description of this report at:-

https://www.nextmsc.com/report/antibiotics-market

Top Companies: Pfizer, Inc. Abbott Laboratories, GlaxoSmithKline PLC, Daiichii Sankyo Company Limited, Bayer HealthCare Pharmaceuticals LLC, Astellas Pharma, Inc., Merck & Company, Inc., Roche Holding AG, Bristol-Myers Squibb Co., Cubist Pharmaceuticals, Inc., and GlaxoSmithKline Plc and others.

Market Dynamics and Trends:

Growing prevalence of infectious diseases across the globe is the major factor that is driving the demand for antibiotics. Additionally, increasing demand for generic drugs, rising geriatric population, increasing research and development investments, and government initiatives with regards to awareness of infectious diseases and antibiotics are some of the other factors contributing to the growth of this market. Moreover, discovery of advanced molecules and novel combination therapies to treat antibiotic-resistant microbial infections are offering significant opportunities in antibiotics market. However, factors such as development of resistance against antibiotics and inadequate pipeline of antibiotics is likely to restrain the growth of antibiotics market.

Request sample copy of this report at:-

https://www.nextmsc.com/antibiotics-market/request-sample

Market Segmentations and Scope of the Study:

Global antibiotics market share is analysed on the basis of type, spectrum, mechanism, distribution channel and geography. On the basis of type, the market is segmented into cephalosporins, penicillins, fluoroquinolones, macrolides, carbapenems, aminoglycosides, sulfonamides, and others. By spectrum the market is further segmented into broad-spectrum antibiotics, and narrow-spectrum antibiotics. The mechanism segment covers the market for cell wall synthesis inhibitors, protein synthesis inhibitors, DNA synthesis inhibitors, RNA synthesis inhibitors, mycolic acid inhibitors, and folic acid synthesis inhibitors. The distribution channel segment covers the market for retail pharmacy, online pharmacy, and hospitals pharmacy. The regional analysis of the market comprises of North America, Europe, Asia Pacific, and Rest of the World.

While there is a clear need for increased antibiotic innovation, focusing only on innovation will not sustain the ability to address serious infections. Many of the market players are entering into strategic alliances which help them make considerable investments in drug discovery. This in turn is expected to develop more number of molecules. For instance, in June 2018, Deinove entered into collaboration with Biomérieux to discover new antibiotics. These and many such strategic developments increases competition and enables companies strengthen their presence in the global antibiotics market.

Contact:
Phone Number: +1-217-650-7991
E-mail: info@nextmsc.com

About Next Move Strategy Consulting:

Next Move Strategy Consulting is an independent and trusted third-platform market intelligence provider, committed to deliver high quality, market research reports that help multinational companies to triumph over their competitions and increase industry footprint by capturing greater market share. Our research model is a unique collaboration of primary research, secondary research, data mining and data analytics.

We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicate as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solution that ranges from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.

For more insights, please visit, https://www.nextmsc.com

This release was published on openPR.